Gilead Sciences Inc (GILD.O) will invest $5.1 billion to raise its stake in Galapagos NV (GLPG.AS) and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the...
UK’s CMA refers Illumina-Pacific Biosciences deal for in-depth investigation
Britain’s competition watchdog said on Thursday it would launch an in-depth investigation into the planned $1.2 billion merger between gene sequencing company Illumina Inc (ILMN.O) and smaller rival Pacific Biosciences...
Biocon board approves sale of branded formulations business to subsidiary
Pharma firm Biocon Monday said it will sell Branded Formulations India (BFI) business on a ‘going concern’ basis to its subsidiary Biocon Biologics India Ltd for Rs 45 crore. The Board of Directors in its...
NCLAT halts liquidation process of Sterling Biotech till further orders
The National Company Law Appellate Tribunal (NCLAT) has stayed the liquidation process of debt-ridden Sterling Biotech till further orders. A two-member NCLAT bench headed by Chairman Justice S J Mukhopadhaya stayed the...
Insolvency case: NCLT orders liquidation of debt-ridden Sterling Biotech
The Bench of the National Company Law Tribunal (NCLT) here has ordered the liquidation of debt-ridden pharmaceutical company Sterling Biotech. This is a setback for its lenders. They were hoping they could withdraw the...
NCLT refers Sterling Biotech for liquidation
The dedicated bankruptcy court has rejected an application from the Sterling Biotech lenders to withdraw their insolvency resolution petition. The lenders, led by Andhra BankNSE 1.67 %, had sought the tribunal’s...
Madison Pacific opposes withdrawal of Sterling Biotech bankruptcy case
Lenders of Sterling Biotech were caught off guard when bondholders’ trustee Madison Pacific Trust Ltd challenged the withdrawal of bankruptcy proceedings initiated by banks on Tuesday saying it held over 10% voting...
NCLT rebukes Sterling Biotech resolution professional, demands explanation
The National Company Law Tribunal (NCLT) reprimanded the resolution professional of Sterling Biotech for failing to discharge his duties and has asked him to submit an explanation as to why he didn’t opt for liquidation...
CCI to hold off Monsanto probe for now
The Competition Commission of India will hold back for now a probe into alleged anti-competition trade practices of the Indian arm of the agri-business giant MonsantoNSE -0.16 %. The self-imposed embargo will continue...
NCLT sees violation of Sec 29(A) in Sterling Biotech case
The National Company Law Tribunal (NCLT) in the Sterling Biotech case for the second time has questioned the motive of lenders, led by Andhra Bank to withdraw their bankruptcy application and to choose a one-time...
NCLT reserves order in Sterling Biotech over settlement issue
Attempt to withdraw the insolvency proceedings against Sterling Biotech by committee of creditors did not materialize and the National Company Law Tribunal reserved its order in the matter and listed the matter for...
NCLT seeks views on Sterling Biotech promoters’ offer
The National Company Law Tribunal (NCLT) has directed the government, regulators, and investigation agencies to clear their stand before the dedicated bankruptcy court decides on the legality of the one-time settlement...
